Impaired ERα action in macrophages is causal for the development of aspects of the metabolic syndrome and increased atherosclerotic lesion formation in female mice [56], consistent with the notion that the atheroprotective effects of estradiol are largely mediated by ERα [57]. Here, ESR1 is linked to metabolic syndrome.